[HTML][HTML] DNA methylation in development and disease: an overview for prostate researchers

DB Joseph, DW Strand, CM Vezina - American journal of clinical …, 2018 - ncbi.nlm.nih.gov
Epigenetic mechanisms including DNA methylation are critical regulators of organismal
development and tissue homeostasis. DNA methylation is the transfer of methyl groups to …

Aberrant DNA methylation and prostate cancer

S Majumdar, E Buckles, J Estrada… - Current …, 2011 - ingentaconnect.com
Prostate cancer (PCa) is the most prevalent cancer, a significant contributor to morbidity and
a leading cause of cancer-related death in men in Western industrialized countries. In …

DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostate

KP Keil, CM Vezina - Epigenomics, 2015 - Future Medicine
Prostate development, benign hyperplasia and cancer involve androgen and growth factor
signaling as well as stromal–epithelial interactions. We review how DNA methylation …

DNA methylation changes in prostate cancer: current developments and future clinical implementation

MO Hoque - Expert review of molecular diagnostics, 2009 - Taylor & Francis
Promoter hypermethylation is associated with the loss of expression of tumor-suppressor
genes in cancer. Currently, several genome-wide technologies are available and have been …

DNA methylation in prostate cancer

LC Li, ST Okino, R Dahiya - Biochimica et Biophysica Acta (BBA)-Reviews …, 2004 - Elsevier
Prostate cancer is the most common malignancy and the second leading cause of cancer
death among men in the United States. There are three well-established risk factors for …

[HTML][HTML] The importance of DNA methylation in prostate cancer development

CE Massie, IG Mills, AG Lynch - The Journal of steroid biochemistry and …, 2017 - Elsevier
After briefly reviewing the nature of DNA methylation, its general role in cancer and the tools
available to interrogate it, we consider the literature surrounding DNA methylation as …

DNA methylation in promoter region as biomarkers in prostate cancer

M Yang, JY Park - Cancer Epigenetics: Methods and Protocols, 2012 - Springer
The prostate gland is the most common site of cancer and the second leading cause of
cancer death in American men. Recent emerging molecular biological technologies help us …

Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia

JM Devaney, S Wang, S Funda, J Long… - Prostate cancer and …, 2013 - nature.com
Background: Prostate cancer (PCa) harbors a myriad of genomic and epigenetic defects.
Cytosine methylation of CpG-rich promoter DNA is an important mechanism of epigenetic …

Promoter hypermethylation in prostate cancer

JY Park - Cancer Control, 2010 - journals.sagepub.com
Background The prostate gland is the most common site of cancer and the second leading
cause of cancer mortality in American men. It is well known that epigenetic alterations such …

Promoter hypermethylation as a biomarker in prostate adenocarcinoma

JY Park - … risk Assessment, Diagnosis, Treatment, and Prognosis, 2015 - Springer
There is increasing evidence that DNA methylation is a critical source of gene regulation. In
addition, interindividual differences in DNA methylation status in cancer related genes are …